Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The "Global Stem Cell Therapy Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Stem Cell Therapy Market is projected to grow at a CAGR of 10.52% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


One trend affecting this market is the rising cost of stem cell therapy procedure. Stem cell transportation is a costly procedure and requires highly specialized tools and resources.

According to the report, one driver influencing this market is the driven by the increasing awareness about stem cell therapy across the globe. Stem cells are cells that have the ability to divide and differentiate into almost every cell type in the body and used in surgery and medicine. With increasing advances in stem cell therapy research, the demand for stem cell therapy procedure is expected to witness a rise over the next few years.

Further, the report states that one challenge affecting this market is the high cost of clinical trials. The high cost of conducting clinical trials on stem cell therapy is high which poses a critical challenge to the growth of the market.


Market Trends

  • Rise in Costs
  • Reimbursement
  • Potential Curative Option for Chronic Diseases
  • Development of IPS Cells

Key Vendors

  • Gilead
  • Novartis
  • Organogenesis
  • Vericel

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: PIPELINE ANALYSIS

  • Pipeline analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: MARKET SEGMENTATION BY TYPE

  • Segmentation by type
  • Comparison by type
  • Autologous transplants - Market size and forecast 2017-2022
  • Allogeneic transplants - Market size and forecast 2017-2022
  • Market opportunity by type

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 11: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

  • Rise in costs
  • Reimbursement
  • Potential curative option for chronic diseases
  • Development of iPS cells

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Gilead
  • Novartis
  • Organogenesis
  • Vericel

For more information about this report visit https://www.researchandmarkets.com/research/4vspqg/stem_cell?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Stem Cells